IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Trident Texofab IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 3.53 Cr. The company is based in Surat and caters to Textiles sector. Guiness Corporate Advisors is the merchant banker of Trident Texofab IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 11th September 2017.
Trident Texofab IPO posted revenues of ₹ 76.19 crores and PAT of ₹ 0.34 crores in FY00 on annualised basis.
Revenue:
₹ 75.95 Cr.
EBITDA Margin:
1.83
% 
Net Worth: ₹ 3.80 Cr.
Market Capitalisation:
[●]
P/E:
35.00 times
P/BV: [●]
EV/EBITDA: 2.44 times
Financial results of Trident Texofab IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY17 | FY16 | FY15 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 24.50 | 37.99 | 28.42 | ||
| Net Worth | 3.80 | 3.46 | 3.43 | ||
| Total Debt | 5.18 | 2.98 | 3.56 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
75.95 | 65.98 | 62.56 | ||
EBITDA
EBITDA on annualised basis |
1.39 | 1.04 | 1.27 | ||
PAT
PAT on annualised basis |
0.34 | 0.06 | 0.18 | ||
Trident Texofab IPO PAT Margin is 0.45 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Trident Texofab IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY17 | FY16 | FY15 |
|---|---|---|---|
| EBITDA Margin (%) | 1.83 | 1.58 | 2.03 |
| PAT Margin (%) | 0.45 | 0.09 | 0.29 |
| EPS (₹) | 1.03 | 0.18 | 0.73 |
| ROE (%) | 8.95 | 1.73 | 5.25 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 1.39 | 0.16 | 0.63 |
| Debt to Equity | 1.36 | 0.86 | 1.04 |
The market Capitalisation of Trident Texofab IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Trident Texofab IPO prospectus highlights an Return on Equity (ROE) of 8.95 % , Return on Assets (ROA) of 1.39 %, and an EBITDA Margin of 1.83 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Trident Texofab IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Trident Texofab IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Trident Texofab IPO has a Price-to-Earnings (PE) ratio of 35.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Trident Texofab IPO reported revenue of ₹ 76.19 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Trident Texofab IPO provide insights into sales growth, market demand, and business scalability.
Trident Texofab recorded an EBITDA of ₹ 1.39 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Trident Texofab Profit After Tax (PAT) is ₹ 0.34 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 75.95 Cr.
EBITDA Margin:
1.83
%
Net Worth: ₹ 3.80 Cr.
Market Capitalisation:
[●]
P/E:
35.00 times
P/BV: [●]
EV/EBITDA: 2.44 times
Trident Texofab operates in Textiles and Company And Its Range Includes Home Furnishing Bed Sheets Scarf Pareos Suiting And Shirting And Technical Textile Fabrics. The Issue is listed on BSE SME in Oct, 2017. Trident Texofab IPO size was 3.53 with Issue price of 30.00 .
Merchant Banker(s) of Trident Texofab IPO: Guiness Corporate Advisors Private Limited
Trident Texofab IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Trident Texofab IPO listed at a listing price of 68.00 against the offer price of 30.00.
The current market price of Trident Texofab is 215.55.
Why Us?
